What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics | PLOS Pathogens
National Coordination Centre for Rare Diseases at Faculty Hospital Motol Národní koordinační centrum ve Fakultní nemocnici
CONSOLIDATED FINANCIAL STATEMENTS OF THE F.I.L.A. GROUP SEPARATE FINANCIAL STATEMENTS OF F.I.L.A. S.p.A.
What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics | PLOS Pathogens
![What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics. - Abstract - Europe PMC What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5739508/bin/ppat.1006762.g002.jpg)
What matters in chronic Burkholderia cenocepacia infection in cystic fibrosis: Insights from comparative genomics. - Abstract - Europe PMC
![PCR detection of Burkholderia cepacia complex as one of key factors to handle a long-term outbreak - Journal of Cystic Fibrosis PCR detection of Burkholderia cepacia complex as one of key factors to handle a long-term outbreak - Journal of Cystic Fibrosis](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b1c16646-800c-4873-bbe4-eb3d1df729af/gr1_lrg.jpg)
PCR detection of Burkholderia cepacia complex as one of key factors to handle a long-term outbreak - Journal of Cystic Fibrosis
![Libor FILA | Head of Department of Pneumology | Assoc. Prof., MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pneumology (2. LF) Libor FILA | Head of Department of Pneumology | Assoc. Prof., MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pneumology (2. LF)](https://www.researchgate.net/profile/Libor-Fila/publication/256445402/figure/fig1/AS:297992172130313@1448058278813/Correlations-between-EBC-NO-concentration-and-clinical-parameters-in-CF-patients-Signi_Q320.jpg)
Libor FILA | Head of Department of Pneumology | Assoc. Prof., MD, PhD | Charles University in Prague, Prague | CUNI | Department of Pneumology (2. LF)
![Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - ScienceDirect Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1569199321013047-gr2.jpg)
Response to elexacaftor/tezacaftor/ivacaftor in intestinal organoids derived from people with cystic fibrosis - ScienceDirect
![Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study | SpringerLink Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10198-015-0759-9/MediaObjects/10198_2015_759_Fig1_HTML.gif)